首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer medicine

缩写:CANCER MED-US

ISSN:2045-7634

e-ISSN:2045-7634

IF/分区:3.1/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引8518
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Yuta Katai,Tatsuya Kamitori,Satoshi Saida et al. Yuta Katai et al.
Introduction: Recent advancements in risk stratification have greatly improved outcomes in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Despite favorable prognostic indicators, including the absence ...
Xiaojing Li,Xiaohui Lai,Xiaolin Wang et al. Xiaojing Li et al.
Background: Thrombocytopenia is less common but shows high risk of early mortality in newly diagnosed multiple myeloma (NDMM) patients. In the era of novel agents-based induction therapy (NAIT), it is unclear whether NAIT...
Heather Derry-Vick,Neil J Shah,Jaeil Ahn et al. Heather Derry-Vick et al.
Introduction: Anxiety and depression can affect immune function, yet little is known about their impact on immune checkpoint inhibitor (ICI) therapy outcomes. We investigated associations between an existing anxiety or de...
Takahito Awatsu,Hidekazu Hirano,Kengo Nagashima et al. Takahito Awatsu et al.
Background: Gastrointestinal stromal tumor (GIST) occurs predominantly in the elderly population. However, clinical data on the outcomes of treatment with imatinib in elderly patients are limited. The aim of this study wa...
Shuning Wu,Jianhao Du,Yifei Wang et al. Shuning Wu et al.
Background: Breast cancer is a common tumor in women, which significantly impacts their health and quality of life. The incidence of breast cancer has been increasing globally. ...
Yanru Chen,Junjie Cao,Rong Huang et al. Yanru Chen et al.
Background: Prostate cancer remains one of the most prevalent cancers among men worldwide, particularly in the context of metastatic castration-resistant prostate cancer (mCRPC), which poses significant treatment challeng...
Masayoshi Nagata,Eiji Kikuchi,Taito Ito et al. Masayoshi Nagata et al.
Introduction: Avelumab maintenance therapy was approved in Japan for curatively unresectable urothelial carcinoma (UC) without progression after prior platinum-based chemotherapy (PBC) based on results from the JAVELIN Bl...
Eiji Kikuchi,Masayoshi Nagata,Taito Ito et al. Eiji Kikuchi et al.
Background: Avelumab maintenance therapy was approved in Japan in February 2021 for the treatment of curatively unresectable urothelial carcinoma (UC) that has not progressed after prior chemotherapy based on results from...
Huandong Huo,Xiaoli Zhang,Qi Zhang et al. Huandong Huo et al.
Background: The noninvasive prediction of pathological high-risk factors in stage I NSCLC patients before surgery remains an area for further investigation, and circulating stem cancer cells are a potential predictive dia...